Arin Bose

VP for Drug Substance Process Development at Akero

Dr. Arindam (“Arin”) Bose is Vice President for Drug Substance Process Development at Akero. Arin retired from Pfizer’s Research & Development team in 2016 after 34 years in leadership roles in bioprocess development and clinical manufacturing. For the last six years of his Pfizer tenure, Arin served as Vice-President, Biotherapeutics Pharmaceutical Sciences External Affairs and Biosimilar Strategy with responsibility for external sourcing, competitive intelligence and external influencing, as well as for executing the technical development plan for Pfizer’s entry into biosimilars. He was a member of the Bioprocess Leadership Team, Pfizer’s most senior oversight body for technical development and manufacturing of biotechnology products. Arin is widely recognized as a thought leader in the biopharmaceutical industry. He has served as chair of the Biologics and Biotechnology Leadership Committee of the Pharmaceutical Research and Manufacturers of America (PhRMA). He was elected to the US National Academy of Engineering for innovations in biomanufacturing. Arin holds a Ph.D. in chemical engineering from Purdue University, M.S. from the University of Michigan, Ann Arbor and B. Tech from the Indian Institute of Technology, Kanpur.

Links

Previous companies

Battelle logo
Pfizer logo

Timeline

  • VP for Drug Substance Process Development

    Current role

A panel showing how The Org can help with contacting the right person.